Utah Medical Products, Inc. (UTMD) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Utah Medical Products, Inc. (UTMD) Healthcare & Pipeline Overview

Utah Medical Products, Inc., established in 1978, develops and distributes specialized medical devices for niche markets including women's health, neonatal care, and critical care. With a focus on high-margin products and direct sales, UTMD maintains a strong market position within its targeted healthcare segments, reflected in its consistent profitability.

What Is the Investment Thesis for UTMD?

Utah Medical Products presents a compelling investment case due to its focus on niche markets within the medical device industry, resulting in high profit margins (28.9%) and a strong gross margin (53.6%). The company's consistent profitability, coupled with a dividend yield of 1.89%, offers a blend of value and income. Growth catalysts include expanding its product offerings within existing markets and penetrating new geographic regions. However, potential risks include competition from larger medical device companies and regulatory changes affecting product approvals. The company's low beta of 0.35 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

UTMD Key Highlights

• Market capitalization of $221M, reflecting its position as a smaller player in the medical device industry.
• P/E ratio of 18.4, indicating a valuation in line with earnings.
• Profit margin of 28.9%, significantly higher than the industry average, demonstrating operational efficiency.
• Gross margin of 53.6%, showcasing strong pricing power and cost management.
• Dividend yield of 1.89%, providing a steady income stream for investors.

Who Are UTMD's Competitors?

UTMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are UTMD's Key Strengths?

• High profit margins
• Specialized product portfolio
• Strong relationships with healthcare providers
• Consistent profitability

What Are UTMD's Weaknesses?

• Limited scale compared to larger competitors
• Dependence on niche markets
• Potential for product liability claims
• Geographic concentration in the United States

What Could Drive UTMD Stock Higher?

• Potential FDA approval for new medical devices in the women's health segment.
• Expansion of direct sales force to increase market penetration.
• Strategic partnerships with international distributors to expand global reach.
• Launch of new telemedicine-compatible devices for remote patient monitoring.

What Are the Key Risks for UTMD?

• Increased competition from larger medical device companies.
• Regulatory changes affecting product approvals and reimbursement rates.
• Product liability claims and recalls.
• Economic downturn impacting healthcare spending.

What Are the Growth Opportunities for UTMD?

• Expansion into International Markets: Utah Medical Products has the opportunity to expand its presence in international markets, particularly in Europe and Asia. These regions have a growing demand for advanced medical devices, driven by increasing healthcare expenditure and aging populations. By establishing strategic partnerships and obtaining regulatory approvals in these markets, UTMD can significantly increase its revenue base. The global market for medical devices is expected to grow, presenting a substantial opportunity for UTMD to capitalize on international expansion.
• New Product Development and Innovation: Investing in research and development to introduce new and innovative medical devices can drive future growth. Focusing on unmet needs in women's health, neonatal care, and critical care can lead to the development of proprietary products with high-profit margins. Continuous innovation will also help UTMD maintain a competitive advantage and attract new customers. The timeline for new product development typically ranges from 2-5 years, with potential for significant revenue generation upon successful launch.
• Strategic Acquisitions: Acquiring smaller companies with complementary product lines or technologies can accelerate growth and expand UTMD's market reach. Identifying companies with innovative products or established distribution networks can provide synergies and enhance UTMD's competitive position. Strategic acquisitions can also provide access to new markets and customer segments. The timeline for acquisitions can vary, but typically ranges from 6-12 months to complete due diligence and integration.
• Increased Focus on Direct Sales and Marketing: Strengthening the direct sales force and implementing targeted marketing campaigns can improve customer acquisition and retention. By focusing on direct customer engagement, UTMD can better understand customer needs and tailor its product offerings accordingly. Investing in digital marketing and online channels can also expand UTMD's reach and generate new leads. The impact of increased sales and marketing efforts can be seen within 1-2 years, with potential for significant revenue growth.
• Leveraging Telemedicine and Remote Monitoring: As telemedicine and remote patient monitoring become increasingly prevalent, UTMD can develop and offer devices that support these trends. Integrating its existing products with telemedicine platforms can enhance patient care and improve outcomes. Developing new remote monitoring solutions for neonatal and critical care can also create new revenue streams. The market for telemedicine and remote patient monitoring is expected to grow significantly, presenting a substantial opportunity for UTMD to capitalize on this trend.

What Opportunities Does UTMD Have?

• Expansion into international markets
• New product development and innovation
• Strategic acquisitions
• Increased focus on direct sales and marketing

What Threats Does UTMD Face?

• Competition from larger medical device companies
• Regulatory changes affecting product approvals
• Economic downturn impacting healthcare spending
• Technological obsolescence

What Are UTMD's Competitive Advantages?

• Specialized product portfolio focused on niche markets.
• Strong relationships with healthcare providers in targeted segments.
• Proprietary technologies and patented products.
• High profit margins due to specialized product offerings.

What Does UTMD Do?

Utah Medical Products, Inc., founded in 1978 and headquartered in Midvale, Utah, develops, manufactures, and distributes a range of specialized medical devices. The company focuses on niche markets within the healthcare industry, including women's health, neonatal care, and critical care. Its product portfolio includes fetal monitoring accessories, vacuum-assisted delivery systems, infant respiratory hoods (DISPOSA-HOOD), and blood pressure monitoring systems (DELTRAN PLUS). Additionally, Utah Medical Products offers products such as umbilical vessel catheters (GESCO), peritoneal dialysis sets (DIALY-NATE), silicone oral protection devices (PALA-NATE), and urinary drainage systems (URI-CATH). In the women's health segment, the company provides the LETZ system for cervical lesion excision, along with related generators, electrodes, and evacuators. They also offer Femcare trocars and laparoscopic instruments, as well as electrosurgical devices like EPITOME and OptiMicro. The Filshie Clip system for female surgical contraception is another key product. Other offerings include devices for endoscopic irrigation (PATHFINDER PLUS), urinary incontinence treatment (LIBERTY), and uterine tissue sampling (ENDOCURETTE). The company also provides pressure monitoring accessories and components, including the DELTRAN disposable pressure transducer. Utah Medical Products serves neonatal intensive care units, labor and delivery departments, women's health centers, outpatient clinics, and physician's offices. The company utilizes a direct customer service and sales force, along with independent consultants and manufacturer representatives, to reach its customer base. Utah Medical Products has cultivated a reputation for high-quality, specialized medical devices, contributing to its consistent profitability and market presence.

What Products and Services Does UTMD Offer?

• Develops and manufactures medical devices for the healthcare industry.
• Offers fetal monitoring accessories and vacuum-assisted delivery systems.
• Provides infant respiratory hoods (DISPOSA-HOOD) and blood pressure monitoring systems (DELTRAN PLUS).
• Supplies umbilical vessel catheters (GESCO) and peritoneal dialysis sets (DIALY-NATE).
• Offers products for women's health, including the LETZ system and Filshie Clip system.
• Provides devices for urinary incontinence treatment (LIBERTY) and uterine tissue sampling (ENDOCURETTE).
• Distributes pressure monitoring accessories and components, including the DELTRAN disposable pressure transducer.

How Does UTMD Make Money?

• Develops and manufactures specialized medical devices.
• Sells products directly to hospitals, clinics, and physician's offices.
• Utilizes a direct sales force, independent consultants, and manufacturer representatives.
• Focuses on niche markets within women's health, neonatal care, and critical care.

What Industry Does UTMD Operate In?

Utah Medical Products operates within the medical device industry, which is characterized by technological innovation, stringent regulatory requirements, and intense competition. The global medical device market is projected to reach $600 billion by 2026, driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. Utah Medical Products focuses on niche segments within this market, such as women's health and neonatal care, allowing it to maintain a competitive edge through specialized products and targeted marketing strategies. Key competitors include larger medical device companies with broader product portfolios.

Who Are UTMD's Key Customers?

• Neonatal intensive care units
• Labor and delivery departments
• Women's health centers in hospitals
• Outpatient clinics
• Physician's offices

UTMD Valuation & Market Position

With a $221M market cap, Utah Medical Products, Inc. sits in the micro-cap segment of the market. Relative to its peer group, UTMD's quantitative score of 89/100 is above the peer average of 68/100.

ROE 9%Key Financial Metrics

Return on equity for Utah Medical Products, Inc. stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.7%, showing how much profit it generates from its asset base. UTMD trades at a trailing price-to-earnings ratio of 18.36, below the Healthcare sector average of ~23x. Its free cash flow yield is 6.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 28.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9Financial Health

Utah Medical Products, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 36.32 places it in the safe zone, indicating low near-term bankruptcy risk.

UTMD Financials

UTMD Latest News

No recent news available for UTMD.

UTMD Analyst Consensus

UTMD MoonshotScore

UTMD Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources